Masimo: Company Discloses CID from DOJ Relating to False Claims Act; SEC Subpoena Around Potential Accounting Irregularities

Published on May 08, 2024

Medical device manufacturer Masimo (MASI) revealed in its 10-Q quarterly filing yesterday that it received a civil investigative demand (CID) from the Department of Justice (DOJ), seeking documents and information pursuant to the False Claims Act (FCA) related to customer returns of Masimo’s Rad-G and Rad-97 devices.

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

© 2024 the Capitol Forum